An Open-Label Study of Lumateperone in Pediatric Subjects with Schizophrenia
- Ages 13-17
- Diagnosis or symptoms of schizophrenia without catatonia
- Must be able to swallow a capsule and comply with all study procedures
- Must maintain an outpatient status for the duration of the study
- If you have history of medical issues such as seizures, blood disorders, or other major health conditions you may not qualify for this trial
- Method of Administration : Oral / Capsule
- Length/Duration: 56 monthly visits
- Location: 721 North Magnolia Avenue, Orlando FL 32803
- Compensation: $100 / visit
- Participants may:
- See a doctor or medical staff at no cost
- Have access to trial medications
- Receive compensation for time and travel